Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Stacey Deleria Finley, PhD

    TitleAssistant Professor
    SchoolViterbi School of Engineering, BME
    DepartmentBiomedical Engineering
    AddressDRB 172
    University Park Campus
    Los Angeles California 90089-1111
    Phone+1 213 740 8788
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Stacey Finley joined the Biomedical Engineering Department at USC in 2013. Dr. Finley received her Bachelor's degree in Chemical Engineering from Florida A & M University in 2004. She pursued graduate studies in Chemical Engineering and received her Ph.D. in 2009 from Northwestern University. While at Northwestern, Dr. Finley was a recipient of the NSF Graduate Research Fellowship and a participant in the NIH Biotechnology Predoctoral Training Program. Following her graduate work, Dr. Finley was a postdoctoral research fellow at Johns Hopkins University School of Medicine. She was awarded postdoctoral fellowships from the NIH National Research Service Award (NRSA) and the UNCF/Merck Science Initiative. She is a member of American Association of Cancer Research (AACR), American Institute of Chemical Engineers (AIChE), Biomedical Engineering Society (BMES), International Society for Computational Biology (ISCB), and the Society of Mathematical Biology (SMB).

      Collapse Biography 
      Collapse Awards and Honors
      2016Keystone Symposia Fellow
      Diverse: Issues in Higher Education2015Emerging Scholar Award
      National Academy of Engineering2014Frontiers in Engineering Education
      University of Southern California2013WiSE Gabilan Assistant Professorship
      Journal Biotechnology and Bioengineering2010Elmer Gaden Jr. Award
      National Institutes of Health2010Ruth L. Kirschstein NRSA Postdoctoral Fellowship
      UNCF/Merck Science Initiative2010Postdoctoral Science Research Fellowship
      National Science Foundation2006Graduate Research Fellowship

      Collapse ORNG Applications 
      Collapse Websites
      Collapse Featured Videos
      Collapse In The News
      Collapse Twitter

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Typpo KV, Wong HR, Finley S, Daniels RC, Seely AJ, Lacroix J. Monitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies. Pediatr Crit Care Med. 2017 Mar; 18(3_suppl Suppl 1):S24-S31. PMID: 28248831.
        View in: PubMed
      2. Chu LH, Ganta VC, Choi MH, Chen G, Finley S, Annex BH, Popel AS. A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF165b in peripheral arterial disease in human and mouse. Sci Rep. 2016 Nov 17; 6:37030. PMID: 27853189.
        View in: PubMed
      3. Rohrs JA, Wang P, Finley S. Predictive Model of Lymphocyte-Specific Protein Tyrosine Kinase (LCK) Autoregulation. Cell Mol Bioeng. 2016; 9:351-367. PMID: 27547268.
        View in: PubMed
      4. Soto-Ortiz L, Finley S. A cancer treatment based on synergy between anti-angiogenic and immune cell therapies. J Theor Biol. 2016 Apr 7; 394:197-211. PMID: 26826488.
        View in: PubMed
      5. Finley S, Angelikopoulos P, Koumoutsakos P, Popel AS. Pharmacokinetics of Anti-VEGF Agent Aflibercept in Cancer Predicted by Data-Driven, Molecular-Detailed Model. CPT Pharmacometrics Syst Pharmacol. 2015 Nov; 4(11):641-9. PMID: 26783500; PMCID: PMC4716581.
      6. Finley S, Chu LH, Popel AS. Computational systems biology approaches to anti-angiogenic cancer therapeutics. Drug Discov Today. 2015 Feb; 20(2):187-97. PMID: 25286370; PMCID: PMC4336587.
      7. Logsdon EA, Finley S, Popel AS, Mac Gabhann F. A systems biology view of blood vessel growth and remodelling. J Cell Mol Med. 2014 Aug; 18(8):1491-508. PMID: 24237862; PMCID: PMC4190897.
      8. Finley S, Dhar M, Popel AS. Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice. Front Oncol. 2013; 3:196. PMID: 23908970; PMCID: PMC3727077.
      9. Finley S, Popel AS. Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions. J Natl Cancer Inst. 2013 Jun 05; 105(11):802-11. PMID: 23670728; PMCID: PMC3672077.
      10. Finley S, Popel AS. Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms. AAPS J. 2012 Sep; 14(3):500-9. PMID: 22547351; PMCID: PMC3385824.
      11. Finley S, Engel-Stefanini MO, Imoukhuede PI, Popel AS. Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies. BMC Syst Biol. 2011 Nov 21; 5:193. PMID: 22104283; PMCID: PMC3229549.
      12. Yen P, Finley S, Engel-Stefanini MO, Popel AS. A two-compartment model of VEGF distribution in the mouse. PLoS One. 2011; 6(11):e27514. PMID: 22087332; PMCID: PMC3210788.
      13. Klinke DJ, Finley S. Timescale analysis of rule-based biochemical reaction networks. Biotechnol Prog. 2012 Jan-Feb; 28(1):33-44. PMID: 21954150; PMCID: PMC3381993.
      14. Finley S, Gupta D, Cheng N, Klinke DJ. Inferring relevant control mechanisms for interleukin-12 signaling in naïve CD4+ T cells. Immunol Cell Biol. 2011 Jan; 89(1):100-10. PMID: 20479776; PMCID: PMC3004982.
      15. Finley S, Broadbelt LJ, Hatzimanikatis V. In silico feasibility of novel biodegradation pathways for 1,2,4-trichlorobenzene. BMC Syst Biol. 2010 Feb 02; 4:7. PMID: 20122273; PMCID: PMC2830930.
      16. Finley S, Broadbelt LJ, Hatzimanikatis V. Computational framework for predictive biodegradation. Biotechnol Bioeng. 2009 Dec 15; 104(6):1086-97. PMID: 19650084; PMCID: PMC4073782.
      17. Finley S, Broadbelt LJ, Hatzimanikatis V. Thermodynamic analysis of biodegradation pathways. Biotechnol Bioeng. 2009 Jun 15; 103(3):532-41. PMID: 19288443; PMCID: PMC4073797.